1 completed, 1 unknown, 1 withdrawn. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Unknown 1, Withdrawn 1 |
Follow Humoral Hypercalcemia Of Malignancy: new trials by email Literature Review of Humoral Hypercalcemia Of Malignancy trials Research Report on Humoral Hypercalcemia Of Malignancy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone ibandronate, zoledronate, quality-of-life assessment - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Withdrawn | SWOG Cancer Research Network | 2006-05-01 | 2013-11-13 | |
| Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer ibandronate sodium, zoledronic acid, Zolendronic Acid - Breast Cancer, Hypercalcemia of Malignancy | Phase 3 | Unknown | Wales Cancer Trials Unit | 1404 | 2006-01-01 | 2013-03-13 |
| Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone zoledronic acid, quality-of-life assessment - Hypercalcemia of Malignancy, Lung Cancer | Phase 3 | Completed | Novartis | 600 | 1998-08-01 | 2013-02-21 |
Neoplasm Metastasis (3) · Breast Neoplasms (2) · Pain (2) · Breast Neoplasms, Male (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1) · Small Cell Lung Carcinoma (1)
Neoplasms (3) · Neoplasms by Site (3) · Neoplastic Processes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Breast Diseases (2) · Neurologic Manifestations (2) · Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1)
Zoledronic Acid (3) · Ibandronic Acid (2)
Novartis (1) · SWOG Cancer Research Network (1) · Wales Cancer Trials Unit (1)
United Kingdom (1) · United States (1)
Dawn Hershman, MD (1) · Kathy S. Albain, MD (1) · Peter J. Barrett Lee, MD (1) · Robert Knight, MD (1) · Saul E. Rivkin, MD (1)
U10CA037429 (1)